subject area of
- 2006 Canadian clinical practice guidelines on the management and prevention of obesity in adults and children [summary] Academic Article
- Cardiovascular Safety of Lorcaserin in Overweight or Obese Patients Academic Article
- Current Weight Management Approaches Used by Primary Care Providers in Six Multidisciplinary Healthcare Settings in Ontario Academic Article
- Evaluating the evidence for macrophage presence in skeletal muscle and its relation to insulin resistance in obese mice and humans: a systematic review protocol Academic Article
- Implementing antiobesity treatment in a patient with a mood disorder. Academic Article
- Long-term persistence with orlistat and sibutramine in a population-based cohort Academic Article
- Management of hypertension in overweight and obese patients: A practical guide for clinicians Academic Article
- Orlistat and Acute Kidney Injury: An Analysis of 953 Patients Academic Article
- Pharmacotherapy for adults with overweight and obesity: a systematic review and network meta-analysis of randomised controlled trials Academic Article
- Scriptaid enhances skeletal muscle insulin action and cardiac function in obese mice Academic Article
- Should family physicians prescribe medication for obesity? NO. Academic Article
- Should family physicians prescribe medication for obesity? YES. Academic Article
- Systematic review of long-term weight loss studies in obese adults: clinical significance and applicability to clinical practice Academic Article
- The Canadian Network for Mood and Anxiety Treatments (CANMAT) task force recommendations for the management of patients with mood disorders and comorbid metabolic disorders. Academic Article
- The Management of Hypertension in the Overweight and Obese Patient Academic Article
- The effectiveness of interventions to treat hypothalamic obesity in survivors of childhood brain tumours: a systematic review Academic Article
- The effectiveness of interventions to treat obesity in survivors of childhood brain tumors: a systematic review protocol Academic Article
- The endocannabinoid system and rimonabant: a new drug with a novel mechanism of action involving cannabinoid CB1receptor antagonism ? or inverse agonism ? as potential obesity treatment and other therapeutic use Academic Article